Bioxcel Therapeutics shares owned by Davenport & Co
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Davenport & Co
from 13F filings
Historical chart of Davenport & Co investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Davenport & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Davenport & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $104k | 35k | 2.95 |
| 2023-09-30 | $156k | 62k | 2.53 |
| 2023-06-30 | $398k | 60k | 6.66 |
| 2023-03-31 | $1.5M | 80k | 18.66 |
| 2022-12-31 | $3.4M | 157k | 21.48 |
| 2022-09-30 | $1.3M | 109k | 11.82 |
| 2022-06-30 | $1.1M | 86k | 13.20 |
| 2022-03-31 | $704k | 34k | 20.90 |
| 2021-12-31 | $705k | 35k | 20.33 |
| 2021-09-30 | $685k | 23k | 30.35 |
| 2021-06-30 | $405k | 14k | 29.08 |
| 2021-03-31 | $1.0M | 24k | 43.15 |
| 2020-12-31 | $328k | 7.1k | 46.20 |